Merck & Co., Inc. (LON:MRK)

Market Cap	149.65B
Revenue (ttm)	46.43B
Net Income (ttm)	11.97B
Shares Out	n/a
EPS (ttm)	4.73
PE Ratio	12.50
Forward PE	8.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,295
Average Volume	21,584
Open	57.00
Previous Close	60.50
Day's Range	57.00 - 59.53
52-Week Range	48.00 - 66.00
Beta	0.69
RSI	47.72
Earnings Date	Jul 29, 2025

About Satixfy Communications

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu...

• Industry: Specialty Retail
• Sector: Consumer Discretionary
• Founded: 1891
• Employees: 75,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: MRK

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.